Your search returned 4 results.

Sort
Results
1.
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. MedStar authors:
  • Venna, Suraj S
PMID:
  • 22511720
Year: 2012
Citation:
  • Proceedings of the National Academy of Sciences of the United States of America. 109(18):7067-72, 2012 May 1.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bezrookove V, Bienvenu G, Billings P, Climent J, Dar AA, De Semir D, Debs R, Federman S, Haqq C, Kashani-Sabet M, Leong SP, Meyer Tamguney TM, Miller JR 3rd, Nosrati M, Rangel J, Sagebiel RW, Thummala S, Tong S, Venna S
2.
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23685835
Year: 2013
Citation:
  • Clinical Cancer Research. 19(13):3681-92, 2013 Jul 1.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bais C, Brauer MJ, Chen D, Cheng JH, Chung AS, Clermont AC, Ferrara N, Haley B, Hegde P, James CD, Jubb A, Jurinka SS, Kaminker JS, Koeppen H, Kolumam G, Modrusan Z, Ozawa T, Phillips H, Scherer SJ, Schmidt M, Singh M, Stephan JP, Swain SM, Tam RN, Wu X, Yang SX, Yao J, Yeh RF, Yue P, Zhuang G
3.
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24930388
Year: 2014
Citation:
  • Cancer. 120(17):2657-64, 2014 Sep 1.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bloom KJ, Brammer MG, Burris H, Chau M, Gralow JR, Kaufman PA, Lalla D, Mayer M, Pegram M, Rugo HS, Swain SM, Vogel CL, Yardley DA, Yoo B
4.
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25559813
Year: 2015
Citation:
  • Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
Pages

Powered by Koha